| Revenue | NOK 26,1M | +82% |
| EBITDA | NOK 4,6M | +105% |
| Net profit | NOK 3,6M | +105% |
| Total assets | NOK 13,1M | +60% |
| Equity | NOK 2,6M | -11% |
| Employees | 15 | — |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 15 881 | 14 886 | 19 646 | 14 335 | 26 088 |
| Staff expenses | −10 370 | −11 751 | −12 615 | −9 406 | −15 484 |
| EBITDA | 4 000 | 1 533 | 4 705 | 2 239 | 4 599 |
| Depreciation & amort. | −0 | −0 | −0 | −2 | −11 |
| EBIT | 4 000 | 1 533 | 4 705 | 2 236 | 4 587 |
| Net financials | −59 | −2 | −1 | 4 | 3 |
| Profit before tax | 3 942 | 1 531 | 4 704 | 2 241 | 4 590 |
| Tax | 867 | 337 | 1 035 | 496 | 1 011 |
| Net profit | 3 075 | 1 194 | 3 669 | 1 745 | 3 579 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 6 084 | 5 675 | 10 045 | 8 167 | 13 058 |
| Equity | 2 135 | 2 339 | 3 008 | 2 953 | 2 633 |
| Long-term debt | 0 | 0 | 0 | 1 | 2 |
| Short-term debt | 3 948 | 3 335 | 7 036 | 5 213 | 10 424 |
| Total debt | 3 948 | 3 335 | 7 036 | 5 214 | 10 426 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EB Chief Executive Officer | Chief Executive Officer | 2019 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2023 | |
| Chairman | 2023 | |
| Former (2) | ||
| Board of Directors | 2023 – 2024 | |
| Board of Directors | 2019 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Medhouse Ab | Company | 67% | 67% | 2024 |
| Company | 33% | 33% | 2024 | |
Åsa Rune & Partners Ab | Company | 8% | 8% | 2023 |
| Individual | 4% | 4% | 2022 | |
| Individual | 4% | 4% | 2022 |
| Person | Role here | Other companies |
|---|---|---|
| Edvin Borgheim | Chief Executive Officer | 0 companies |
| Per Goeran Oeberg | Board of Directors | 0 companies |
| Tomas Ludvigsson | Chairman | 0 companies |
| Åsa Cecilia Rune | Board of Directors | 0 companies |
| Henrik Gattermann | Board of Directors | 0 companies |